HRTS.US Tema Cardiovascular and Metabolic ETF

- USD
No recent price
Total assets
58.4M
Expense ratio
0.76%
Dividend yield
1.24%
1-year return
+17.20%
Holdings
45
Since
2023

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does HRTS.US invest in?

  • Mostly US stocks (81.1%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (79.3%)
  • Top 3 holdings: 22.3% of the fund

Asset allocation

  • US stocks 81.1%
  • Non-US stocks 18.8%

Top holdings

All holdings, sectors and regions

Tema Cardiovascular and Metabolic ETF performance

Sharpe ratio 0.00
This year
+11.27%
1 year
+17.20%
3 years
-
5 years
-

Volatility 15.9% over 1 year. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

HRTS.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Tema Cardiovascular and Metabolic ETF

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 co…

Full fund profile